Strengthening the Access to Rare Disease Treatment in India
Orchestrating Collaborative Actions to Generate Rare Disease Crowdfunding Takeda and United Nations Global Compact Network of India (UNGCNI) Join Hands Bangalore, 9 May 2022: In November 2021, Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, together with UNGCNI launched a national initiative for improving early access to treatment for Rare Disease Patients in
Source: newspatrolling.com